Back
Expedia Group Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
45
EXPE
Expedia Group
Last Price:
125.88
Seasonality Move:
-1.91%
Sell
50
ITCI
Intra-Cellular Therapies
Last Price:
80.46
Seasonality Move:
-0.5%
Sell
45
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $124.90. The Score for EXPE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $80.85. The Score for ITCI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $124.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $80.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.98 | Buy |
| Relative Strength Index (14 RSI): | 43.94 | Sell |
| Chaikin Money Flow: | 534744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.51 - 133.41) | Sell |
| Bollinger Bands (100): | (117.98 - 135.72) | Sell |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 67.53 | Buy |
| Chaikin Money Flow: | 852610 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.71 - 78.23) | Buy |
| Bollinger Bands (100): | (65.7 - 74.06) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.15 | Sell |
| 20-day SMA: | 129.28 | Sell |
| 50-day SMA: | 122.67 | Buy |
| 200-day SMA: | 129.94 | Sell |
| 8-day EMA: | 130.64 | Sell |
| 20-day EMA: | 129.58 | Sell |
| 50-day EMA: | 126.87 | Sell |
| 200-day EMA: | 125.99 | Sell |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.22 | Buy |
| 20-day SMA: | 74.52 | Buy |
| 50-day SMA: | 71 | Buy |
| 200-day SMA: | 66.4 | Buy |
| 8-day EMA: | 77.56 | Buy |
| 20-day EMA: | 75.47 | Buy |
| 50-day EMA: | 72.68 | Buy |
| 200-day EMA: | 67.34 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.43 per share, a decrease next quarter of $2.64 per share, an increase this year of $2.07 per share, and an increase next year of $2.81 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.57 per share.
Expedia Group Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||